Is this the market’s ultimate bargain corner?
Tim Boreham, Stockhead’s small caps correspondent joins The Australian’s Wealth Editor James Kirby on this week’s show. They discuss how Biotech gets hit hardest of all, one reason this sector may recover first and three ASX biotech stocks for you to consider.
Previous Episodes
Why younger investors are not putting money into super
Charity giving: Australia you’re doing it wrong
Bank stocks are back in fashion: But which one?
Ukraine Donations – Are they tax deductible?
BONUS – Live web event for The Australian’s subscribers
What we found out about inflation from Treasurer Frydenberg
Join the conversation
To join the conversation, please log in. Don't have an account? Register
Join the conversation, you are commenting as Logout